Smoldering Multiple Myeloma Presenting as Immune Thrombocytopenia.
作者信息
Jain Ankur, Khunger J M, Kapahtia Siddharth, Prasad Pooja, Gupta D K, Chaudhry Sumita
机构信息
Department of Hematology, Vardhman Mahavir Medical College and Safdarjang Hospital, New Delhi, 110029 India.
出版信息
Indian J Hematol Blood Transfus. 2019 Jul;35(3):565-566. doi: 10.1007/s12288-019-01094-w. Epub 2019 Feb 13.
Abstract
摘要
相似文献
1
Smoldering Multiple Myeloma Presenting as Immune Thrombocytopenia.
Indian J Hematol Blood Transfus. 2019 Jul;35(3):565-566. doi: 10.1007/s12288-019-01094-w. Epub 2019 Feb 13.
2
Shall we treat smoldering multiple myeloma in the near future?我们是否应该在不久的将来治疗冒烟型多发性骨髓瘤？
Hematology Am Soc Hematol Educ Program. 2017 Dec 8;2017(1):194-204. doi: 10.1182/asheducation-2017.1.194.
3
Smoldering Multiple Myeloma: Emerging Concepts and Therapeutics.冒烟型多发性骨髓瘤：新出现的概念与治疗方法
Curr Hematol Malig Rep. 2016 Apr;11(2):102-10. doi: 10.1007/s11899-016-0305-6.
4
Four genes predict high risk of progression from smoldering to symptomatic multiple myeloma (SWOG S0120).四个基因可预测无症状多发性骨髓瘤进展为有症状多发性骨髓瘤的高风险（SWOG S0120）。
Haematologica. 2015 Sep;100(9):1214-21. doi: 10.3324/haematol.2015.124651. Epub 2015 May 28.
5
Monoclonal gammopathy of undetermined significance (MGUS) and smoldering myeloma (SMM): a practical guide to management.意义未明的单克隆丙种球蛋白病（MGUS）和冒烟型骨髓瘤（SMM）：管理实用指南
Hematol Oncol. 2017 Dec;35(4):432-439. doi: 10.1002/hon.2345. Epub 2016 Nov 2.
6
[Recurrent invasive pneumococcal disease in a patient with IgG-κ smoldering multiple myeloma].
Rinsho Ketsueki. 2018;59(1):40-44. doi: 10.11406/rinketsu.59.40.
7
Recent Advances in the Management of Smoldering Multiple Myeloma.冒烟型多发性骨髓瘤治疗的最新进展
World J Oncol. 2020 Apr;11(2):45-54. doi: 10.14740/wjon1245. Epub 2020 Mar 29.
8
Smoldering Myeloma Presenting with Renal Histopathology of Monoclonal Gammopathy of Renal Significance: Adding to the Complexity.隐匿性骨髓瘤伴意义未明的单克隆丙种球蛋白病肾脏组织病理学表现：使情况更为复杂
J Am Soc Nephrol. 2018 Dec;29(12):2901. doi: 10.1681/ASN.2018080864. Epub 2018 Oct 30.
9
Volumetry based biomarker speed of growth: Quantifying the change of total tumor volume in whole-body magnetic resonance imaging over time improves risk stratification of smoldering multiple myeloma patients.基于容积测量的生物标志物生长速度：通过量化全身磁共振成像中总肿瘤体积随时间的变化，可改善冒烟型多发性骨髓瘤患者的风险分层。
Oncotarget. 2018 May 18;9(38):25254-25264. doi: 10.18632/oncotarget.25402.
10
State of the science in smoldering myeloma: Should we be treating in the clinic?冒烟型骨髓瘤的现状：我们是否应该在临床中治疗？
Semin Oncol. 2019 Apr;46(2):112-120. doi: 10.1053/j.seminoncol.2019.03.001. Epub 2019 Apr 24.
引用本文的文献
1
Can you Diagnose Immune Thrombocytopenia in Myeloma? A Case of Thrombocytopenia in a Patient with Multiple Myeloma.你能诊断出骨髓瘤中的免疫性血小板减少症吗？一例多发性骨髓瘤患者的血小板减少症病例。
Eur J Case Rep Intern Med. 2024 Nov 11;11(12):004981. doi: 10.12890/2024_004981. eCollection 2024.
本文引用的文献
1
Autoimmune manifestations in patients with multiple myeloma and monoclonal gammopathy of undetermined significance.多发性骨髓瘤和意义未明的单克隆丙种球蛋白病患者的自身免疫表现。
BBA Clin. 2016 May 25;6:12-8. doi: 10.1016/j.bbacli.2016.05.004. eCollection 2016 Dec.
2
Immune thrombocytopenia purpura associated with multiple myeloma.免疫性血小板减少性紫癜合并多发性骨髓瘤
Ann Hematol. 2016 Aug;95(8):1371-2. doi: 10.1007/s00277-016-2694-y. Epub 2016 May 13.
Zotero 插件